Radiation protective effect of hypoxia-inducible factor-1α (HIF-1α) on human oral squamous cell carcinoma cell lines

Radiation Protection Dosimetry

Volumn 152, Issue 1-3, 2012, Pages 159-163

  Hosokawa, Y ^a   Okumura, K ^b   Terashima, S ^a   Sakakura, Y ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; RADIOPROTECTIVE AGENT;

APOPTOSIS; ARTICLE; CELL LINE; CELL MOTION; CELL SURVIVAL; CULTURE MEDIUM; DENSITOMETRY; GENETIC TRANSCRIPTION; HUMAN; METABOLISM; METHODOLOGY; MOUTH TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TIME; TUMOR CELL LINE; X RAY;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; DENSITOMETRY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MOUTH NEOPLASMS; RADIATION-PROTECTIVE AGENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSCRIPTION, GENETIC; X-RAYS;

EID: 84870461679     PISSN: 01448420     EISSN: 17423406     Source Type: Journal    
DOI: 10.1093/rpd/ncs215     Document Type: Article

References (17)

1. Sheehan, J. P., Shaffrey, M. E., Gupta, B., Larner, J.,Rich, J. N. and Park, D. M. Improving the radiosensitivity of radioresistant and hypoxic glioblastoma. Future Oncol. 6, 1591-1601 (2010).
2. Majmundar, A. J., Wong, W. J. and Simon, M. C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell. 40, 294-309 (2010).
3. Harada, H., Itasaka, S., Zhu, Y., Zeng, L., Xie, X.,Morinibu, A., Shinomiya, K. and Hiraoka, M. Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy. Br. J. Cancer 100, 747-757 (2009).
4. Abiko, Y., Nishimura, M., Kusano, K., Nakashima, K., Okumura, K., Arakawa, T., Takuma, T.,Mizoguchi, I. and Kaku, T. Expression of MIP-3alpha/CCL20, a macrophage inflammatory protein in oral squamous cell carcinoma. Arch. Oral. Biol. 48, 171-175 (2003).
5. Okumura, K., Konishi, A., Tanaka, M., Kanazawa, M., Kogawa, K. and Niitsu, Y. Establishment of highand low-invasion clones derived for a human tongue squamous-cell carcinoma cell line SAS. J. Cancer Res. Clin. Oncol. 122, 243-248 (1996).
6. Ishii, T., Futami, S., Nishida, M., Suzuki, T.,Sakamoto, T., Suzuki, N. and Maekawa, K. Brief note and evaluation of acute-radiation syndrome and treatment of a Tokai-mura criticality accident patient. J. Radiat. Res. 42, S167-S182 (2001).
7. Lee, K. and Kim, H. M. A novel approach to cancer therapy using PX-478 as a HIF-1α inhibitor. Arch. Pharm. Res. 34, 1583-1585 (2011).
8. Harada, H. How can we overcome tumor hypoxia in radiation therapy? J. Radiat. Res. 52, 545-556 (2011).
9. Sakakura, Y., Shibui, T., Irie, K. and Yajima, T. Metabolic mode peculiar to Meckel's cartilage: immunohistochemical comparisons of hypoxia-inducible factor-1alpha and glucose transporters in developing endochondral bones in mice. Eur. J. Oral. Sci. 116, 341-352 (2008).
10. Risbud, M. V., Guttapalli, A., Stokes, D. G., Hawkins, D., Danielson, K. G., Schaer, T. P., Albert, T. J. B. and Shapiro, I. M. Nucleus pulposus cells express HIF-1 alpha under normoxic culture conditions: a metabolic adaptation to the intervertebral disc microenvironment. J. Cell. Biochem. 98, 152-159 (2006).
11. Agrawal, A., Guttapalli, A., Narayan, S., Albert, T.J.,Shapiro, I.M. and Risbud, M.V. Normoxic stabilization of HIF-1alpha drives glycolytic metabolism and regulates aggrecan gene expression in nucleus pulposus cells of the rat intervertebral disk. Am. J. Physiol. Cell. Physiol. 293, C621-C631 (2007).
12. Akakura, N., Kobayashi, M., Horiuchi, I., Suzuki, A.,Wang, J., Chen, J., Niizeki, H., Kawamura, K. i.,Hosokawa, M. and Asaka, M. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res. 61, 6548-6554 (2001).
13. Cho, W. K., Seong, Y. R., Lee, Y. H., Kim, M. J.,Hwang, K. S., Yoo, J., Choi, S., Jung, C. R. and Im, D. S. Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor. Mol. Ther. 10, 938-949 (2004).
14. Moeller, B. J. and Dewhirst, M. W. HIF-1 and tumour radiosensitivity. Br. J. Cancer. 95, 1-5 (2006).
15. Kubo, T., Maezawa, N., Osada, M., Katsumura, S.,Funae, Y. and Imaoka, S. Bisphenol A, an environmental endocrine-disrupting chemical, inhibits hypoxic response via degradation of hypoxia-inducible factor 1alpha (HIF-1alpha): structural requirement of bisphenol A for degradation of HIF-1alpha. Biochem. Biophys. Res. Commun. 318, 1006-1011 (2004).
16. Yook, Y. J., Seo, Y. J., Kang, H. J., Ko, S. H., Shin, H. Y., Lee, J. J., Jeong, G. and Ahn, H. S. Induction of hypoxia-inducible factor-1a inhibits drug-induced apoptosis in the human leukemic cell line HL-60. Korean J. Hematol. 45, 158-163 (2010).
17. Patiar, S. and Harris, A. L. Role of hypoxia-inducible factor-1alpha as a cancer therapy target. Endocr. Relat. Cancer 13(Suppl. 1), S61-S75 (2006).